JEJames O. Early

James O. Early

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James O. Early has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Anne-Maria Curtis

    Curtis Clock Laboratory, School of Pharmacy and Biomolecular Sciences (PBS) Royal College of Surgeons in Ireland (RCSI) Dublin Ireland

    1 shared publication
  • Cathy A. Wyse

    Department of Molecular and Cellular Therapeutics, Tissue Engineering Regenerative Group, Royal College of Surgeons in Ireland, Dublin 2, Ireland

    1 shared publication
  • Daniel O’connell

    Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142

    1 shared publication
  • Darren J. Fitzpatrick

    Department of Genetics, Smurfit Institute, Trinity College Dublin, Dublin 2, Ireland

    1 shared publication
  • Deepthi Menon

    School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland

    1 shared publication
  • Dylan G. Ryan

    School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland

    1 shared publication

Latest Publications

  • Open Access

    Circadian rhythms in adaptive immunity

    by Polly Downton, James O. Early, Julie E. Gibbs

    Summary: The circadian clock provides organisms with the ability to track time of day, allowing them to predict and respond to cyclical changes in the external environment. In mammals this clock consists of multiple auto‐regulatory feedback loops generated by a network of circadian clock proteins. This network provides the fundamental basis for rhythms in behaviour and physiology. This clockwork machinery exists in most cells, including those of the immune system. In recent years evidence has emerged highlighting the important role of molecular clocks in dictating the response of immune pathways. While initial work highlighted the effect of the clock in the ‘first line of defence’, the innate immune system, it has become increasingly apparent that it also plays a role in the more tailored, later‐stage adaptive immune response. This review provides an overview of the role of the circadian cycle in the adaptive immune response. We interrogate the depth of knowledge on cell intrinsic clocks within adaptive immune cells and how these cells may be temporally directed by extrinsic rhythmic signals. We discuss the role of the circadian clock in diseases associated with adaptive immunity such as multiple sclerosis, asthma and parasitic infection. We also discuss the current knowledge on timing of vaccination, and the implications this may have on how we can harness and modulate temporal gating of the adaptive immune response in a clinical setting.


  • Top Cited Papers
    Open Access

    Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2

    by James O. Early, Deepthi Menon, Cathy A. Wyse, Mariana P. Cervantes-Silva, Zbigniew Zaslona, Richard G. Carroll, Eva M. Palsson-McDermott, Stefano Angiari, Dylan G. Ryan, Sarah E. Corcoran, et al.

    Significance: The molecular clock provides an anticipatory mechanism, allowing organisms to prepare and respond to daily changes in the external environment. The response of the innate immune system to pathogenic threats is dependent on time of day; however, the molecular mechanisms underlying this have yet to be fully uncovered. We observe that the core molecular clock component, BMAL1, is crucial in promoting an antioxidant response in myeloid cells. Deletion of Bmal1 in macrophages disrupts NRF2 activity, facilitating accumulation of reactive oxygen species and the proinflammatory cytokine, IL-1β. Thus the molecular clock directly controls NRF2 transcriptional activity and antioxidant capacity to regulate IL-1β in myeloid cells.